Andrew Baschnagel

Associate Professor

University of Wisconsin-Madison

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andrew Baschnagel is an Associate Professor at the University of Wisconsin, United States. His research focuses on the immune and genomic landscape of non-small cell lung cancer, particularly in relation to MET alterations and brain metastases. He has published extensively on topics such as treatment outcomes for patients with lung cancer and interstitial lung disease, stereotactic body radiotherapy, and radiomic modeling in cancer therapies.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Scot Callahan

University of Wisconsin School of Medicine and Public Health

UNITED STATES

View details

Randall Kimple

Associate Professor

University of Wisconsin-Madison

UNITED STATES

View details

Jessica Miller

Associate Professor

University of Wisconsin-Madison

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrew Baschnagel

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Immune and Genomic Heterogeneity of MET-Altered Non–Small Cell Lung Cancer

Outcomes of Patients With Interstitial Lung Disease and Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiotherapy

Genomic and Immune Landscape of Non–Small Cell Lung Cancer Brain Metastases

Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer

A Phase 2 Randomized Clinical Trial Evaluating 4-Dimensional Computed Tomography Ventilation-Based Functional Lung Avoidance Radiation Therapy for Non-Small Cell Lung Cancer

MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer

Radiomic Modeling of Bone Density and Rib Fracture Risk After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer

Impact of immediate cryopreservation on the establishment of patient derived xenografts from head and neck cancer patients

ATR Inhibitor M6620 (VX-970) Enhances the Effect of Radiation in Non-Small Cell Lung Cancer Brain Metastasis Patient-Derived Xenografts.

ATR Inhibitor M6620 (VX-970) Enhances the Effect of Radiation in Non–Small Cell Lung Cancer Brain Metastasis Patient-Derived Xenografts

Combined Immunotherapy and Stereotactic Radiotherapy Improves Neurologic Outcomes in Patients with Non–small-cell Lung Cancer Brain Metastases

Development and characterization of patient-derived xenografts from non-small cell lung cancer brain metastases

Minimally invasive surgery prior to radiation therapy for metastatic spine disease: Decision making and technique

Radiation-induced Hounsfield unit change correlates with dynamic CT perfusion better than 4DCT-based ventilation measures in a novel-swine model

FGFR Inhibition Enhances Sensitivity to Radiation in Non-Small Cell Lung Cancer.

FGFR inhibition enhances sensitivity to radiation in non-small cell lung cancer

Collaborators (3)

Scot Callahan

Randall Kimple

Jessica Miller

Make your next move.